<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002725'>Systemic lupus erythematosus</z:hpo> (SLE) and <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> (APS) are autoimmune <z:e sem="disease" ids="C1290884" disease_type="Disease or Syndrome" abbrv="">inflammatory diseases</z:e> associated with juvenile <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> and <z:mp ids='MP_0005048'>thrombosis</z:mp>, respectively </plain></SENT>
<SENT sid="1" pm="."><plain>A 44-year-old woman who had SLE with secondary APS had been treated with <z:chebi fb="0" ids="50858">corticosteroid</z:chebi> therapy, however, her inflammatory marker had never been within a <z:mpath ids='MPATH_458'>normal</z:mpath> range in her clinical course, and finally <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> was developed </plain></SENT>
<SENT sid="2" pm="."><plain>Intra-vascular ultrasound also revealed diffuse <z:hpo ids='HP_0004929'>coronary atherosclerosis</z:hpo> progression for her age, which might result from SLE and APS, including <z:mp ids='MP_0001863'>vascular inflammation</z:mp> </plain></SENT>
</text></document>